Skip to main content

Table 2 Statistical differences between patients with unexplained female sterility, patients with RPL and control subjects

From: Hyperhomocysteinemia in women with unexplained sterility or recurrent early pregnancy loss from Southern Italy: a preliminary report

 

Hcy (μM/ml)

p

Serum folate (ng/ml)

P

Serum vit. B 12 (pg/ml)

p

MTHFR C677T heterozigosity

p

MTHFR C677T homozigosity

p

UFS vs CG

21.05 ± 8.78 vs 7.85 ± 3.31

<0.01, s

6.70 ± 4.50 vs 20.10 ± 9.44

<0.01, s

648 ± 162 vs 664 ± 175

0.35, ns

5/20 vs 9/20

0.32, ns

15/20 vs 3/20

<0.01, s

UFS vs RPL

21.05 ± 8.78 vs 19.20 ± 6.14

0.44, ns

6.70 ± 4.50 vs 6.10 ± 2.81

0.007, s

648 ± 162 vs 608 ± 154

0.42, ns

5/20 vs 3/20

0.69, ns

15/20 vs 17/20

0.69, ns

RPL vs CG

19.20 ± 6.14 vs 7.85 ± 3.31

<0.01, s

6.10 ± 2.81 vs 20.10 ± 9.44

<0.01, s

608 ± 154 vs vs 664 ± 175

0.20, ns

3/20 vs 9/20

0.08, ns

17/20 vs 3/20

<0.01, s

  1. Hcy: homocysteine
  2. MTHFR: methylenetetrahydrofolate reductase
  3. UFS: unexplained female sterility group
  4. RPL: recurrent pregnancy loss group
  5. CG: control group
  6. ns: not significant
  7. s: significant